CoChat

AlphaFold2 protein structure prediction: Implications for drug discovery

Open access
Borkakoti, Neera, Thornton, Janet M. · 2023 · Current Opinion in Structural Biology
Cited by 128

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

The drug discovery process involves designing compounds to selectively interact with their targets. The majority of therapeutic targets for low molecular weight (small molecule) drugs are proteins. The outstanding accuracy with which recent artificial intelligence methods compile the three dimensional structure of proteins has made protein targets more accessible to the drug design process. Here we present our perspective of the significance of accurate protein structure prediction on various stages of the small molecule drug discovery life cycle focusing on current capabilities and assessing how further evolution of such predictive procedures can have a more decisive impact in the discovery of new medicines.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.sbi.2022.102526

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Research works printed but not linked: 26

  1. Vincent, 2022, Phenotypic drug discovery: recent successes, lessons learned and new directions, Nat Rev Drug Discov, 21, 541, 10.1038/s41573-022-00503-6 · doi:10.1038/s41573-022-00503-6
  2. Sayers, 2022, Karsch-MizrachiI GenBank, Nucleic Acids Res, 50, D161, 10.1093/nar/gkab1135 · DOI · Paper page
  3. Goodsell, 2020, RCSB Protein Data Bank: Enabling biomedical research and drug discovery, Protein Sci, 29, 52, 10.1002/pro.3730 · DOI · Paper page
  4. Ricci-Lopez, 2021, Improving structure-based virtual screening with Ensemble docking and machine learning, J Chem Inf Model, 61, 5362, 10.1021/acs.jcim.1c00511 · DOI · Paper page
  5. Haley, 2020, Functional genomics for cancer drug target discovery, Cancer Cell, 38, 31, 10.1016/j.ccell.2020.04.006 · DOI
  6. Kim, 2020, Artificial intelligence in drug discovery: a Comprehensive review of data-driven and machine learning approaches, Biotechnol Bioproc Eng, 25, 895, 10.1007/s12257-020-0049-y · DOI · Paper page
  7. Attwood, 2020, Soluble ligands as drug targets, Nat Rev Drug Discov, 19, 695, 10.1038/s41573-020-0078-4 · DOI
  8. Goulet, 2022, Structure prediction and analysis of Hepatitis E virus non-structural proteins from the Replication and Transcription Machinery by AlphaFold2, Viruses, 14, 1537, 10.3390/v14071537 · DOI
  9. Goodsell, 2021, The AutoDock suite at 30, Protein Sci, 30, 31, 10.1002/pro.3934 · DOI · Paper page
  10. Armstrong, 2020, PDBe: improved findability of macromolecular structure data in the PDB, Nucleic Acids Res, 48, D335
  11. Hekkelman, 2021, AlphaFill: enriching the AlphaFold models with ligands and co-factors, bioRxiv, 11
  12. Hu, 2022, Lasanajak Y, Smith DF, Crawford SE, EstesMK, Venkataram Prasad BV Novel fold of rotavirus glycan-binding domain predicted by AlphaFold2 and determined by X-ray crystallography, Commun Biol, 5, 419, 10.1038/s42003-022-03357-1 · DOI
  13. Liebeschuetz, 2012, Pose prediction and virtual screening performance of GOLD scoring functions in a standardized test, J Comput Aided Mol Des, 26, 737, 10.1007/s10822-012-9551-4 · DOI · Paper page
  14. Clark, JJ, Orban, ZJ, and Carlson, HA : Predicting binding sites from unbound versus, bound protein structures. Sci Rep 10:15856- · DOI · Paper page
  15. Tang, 2022, Discovery of a Novel Class of d-amino acid Oxidase Inhibitors using the Schrödinger computational platform, J Med Chem, 65, 6775, 10.1021/acs.jmedchem.2c00118 · DOI
  16. Das, 2021, CATH functional families predict functional sites in proteins, Bioinformatics, 37, 1099, 10.1093/bioinformatics/btaa937 · DOI
  17. Zięba, 2022, Kaczor AA what are the challenges with multi-targeted drug design for complex diseases?, Expet Opin Drug Discov, 17, 673, 10.1080/17460441.2022.2072827 · DOI
  18. de Beer, 2014, Laskowski R A PDBsum additions, Nucleic Acids Res, 42, D292, 10.1093/nar/gkt940 · DOI · Paper page
  19. Bryda, 2013, The Mighty Mouse: the impact of rodents on advances in biomedical research, Mo Med, 110, 207
  20. Pehlivanovic, 2019, Animal models in modern biomedical research, Eur J Pharm Med Res, 6, 35
  21. Riziotis, 2022, Thornton JM.:Capturing the geometry, function, and evolution of enzymes with 3D templates, Protein Sci, 31, 10.1002/pro.4363 · DOI
  22. Miller, 2021, Moving beyond static snapshots: protein dynamics and the protein data bank, J Biol Chem, 296, 100749, 10.1016/j.jbc.2021.100749 · DOI · Paper page
  23. Kumar, 2020, vol. 59, 57
  24. Stein, 2021, Modeling Alternate conformations with Alphafold2 via modification of the multiple sequence Alignment, bioRxiv
  25. Jones, 2022, Thornton JM :The impact of AlphaFold2 one year on, Nat Methods, 19, 15, 10.1038/s41592-021-01365-3 · DOI · Paper page
  26. Kuzmanic, 2020, Investigating cryptic binding sites by molecular dynamics Simulations Acc. Chem, Res, 53, 654

Cited by

See all 128

Metadata

Authors
Borkakoti, N., & Thornton, J. M.
Venue
Current Opinion in Structural Biology
Publisher
Elsevier BV
Published
2023-02
Volume
78
Pages
102526
ISSN
0959-440X (ISSN-L)
OpenAlex
W4313654640
Cited by
128
References
28
FWCI
2.57
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: AlphaFold2 protein structure prediction: Implications for drug discovery. https://app.cochat.ai/papers/10.1016/j.sbi.2022.102526
The paper
Borkakoti, N., & Thornton, J. M. (2023). AlphaFold2 protein structure prediction: Implications for drug discovery. Current Opinion in Structural Biology. https://doi.org/10.1016/j.sbi.2022.102526

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.